Connect with us
[ad_1] Ted Kaczynski, the man known as the Unabomber who carried out a 17-year bombing campaign that killed three people and injured 23 others, died by...
[ad_1] Newswise — An LMU study reveals: Whether patients are able to correctly assess risks depends partly on how physicians convey statistical information to them. Medical...
[ad_1] BYLINE: Julia Evangelou Strait Newswise — A new study in mice, led by researchers at Washington University School of Medicine in St. Louis, explains how...
[ad_1] RESEARCH SUMMARY Study Title: Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer Publication: Journal of Clinical Oncology Dana-Farber Cancer Institute authors: Jeremiah Wala; MD, PhD,...
[ad_1] JULIA ROTOW: I’m Dr. Julia Rotow. I’m a thoracic medical oncologist at the Dana-Farber Cancer Institute in Boston, Massachusetts....
[ad_1] Newswise — MIAMI, FLORIDA (EMBARGOED UNTIL JUNE 8, 2023) – A research team at Sylvester Comprehensive Cancer Center at the University of Miami Miller School...
[ad_1] Actor Shannen Doherty posted an honest video about her breast cancer treatment on Tuesday and told fans the disease has spread to her brain. Doherty,...
[ad_1] Experts: Mammograms should start at age 40 Why experts say mammograms should start at age 40 04:42 “Charmed” and “Beverly Hills, 90210” actor Shannen Doherty...
[ad_1] Newswise — JERSEY CITY, N.J., June 5, 2023 /PRNewswire/ — MEDSIR announced today the results of the PALMIRA trial. This randomized phase 2 study evaluated the safety and efficacy...
[ad_1] Biotech company Grail announced on Friday that hundreds of patients were mistakenly informed they may have cancer after purchasing one of its products, Galleri. According...
[ad_1] A biotechnology company selling a $949 blood test that it bills as a “first of its kind” to detect cancer said it incorrectly informed about...
[ad_1] Newswise — CHICAGO – Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many...
[ad_1] Newswise — JERSEY CITY, N.J., June 2, 2023 /PRNewswire/ — MEDSIR announced today the positive results of the PHERGain trial. This study is the first to use an adaptive design...
[ad_1] ABSTRACT: 4008 Newswise — CHICAGO ― HER2-targeted bispecific antibody zanidatamab demonstrated durable responses in patients with treatment-refractory HER2-positive biliary tract cancer (BTC), researchers from The...
[ad_1] Worker labors on a production line at the factory of Qilu Pharmaceutical in Haikou, Hainan province of China, February 11, 2022. Su Bikun | VCG...
[ad_1] Newswise — Amer Zeidan, MBBS, medical director of the hematology early therapeutics research program at Yale Cancer Center and associate professor of medicine (hematology) at...
[ad_1] By Anthony O. Goriainoff AstraZeneca said Thursday that its and MSD’s Lynparza cancer treatment had been approved in the U.S. for the treatment of metastatic...
[ad_1] Newswise — Singapore, 29 May 2023 – A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of...
[ad_1] Newswise — HOUSTON ― A new study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, provides...
[ad_1] Newswise — Boston – Women with obesity when they are diagnosed with early breast cancer have a higher risk of recurrence or a second cancer...